HKI 357 |
| Catalog No.GC14259 |
HKI 357 est un double inhibiteur irréversible de l'EGFR et de l'ERBB2 avec des IC50 de 34 nM et 33 nM, respectivement. HKI 357 supprime l'autophosphorylation d'EGFR (à Y1068) et la phosphorylation d'AKT et de MAPK.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 848133-17-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for HKI 357
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for HKI 357
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *